These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22241958)

  • 1. Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.
    Williams PD; Owens CR; Dziegielewski J; Moskaluk CA; Read PW; Larner JM; Story MD; Brock WA; Amundson SA; Lee JK; Theodorescu D
    Neoplasia; 2011 Dec; 13(12):1122-31. PubMed ID: 22241958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks.
    Michna A; Schötz U; Selmansberger M; Zitzelsberger H; Lauber K; Unger K; Hess J
    Radiat Oncol; 2016 Jul; 11():94. PubMed ID: 27455841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma.
    Jerhammar F; Ceder R; Garvin S; Grénman R; Grafström RC; Roberg K
    Cancer Biol Ther; 2010 Dec; 10(12):1244-51. PubMed ID: 20930522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
    BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.
    de Jong MC; Ten Hoeve JJ; Grénman R; Wessels LF; Kerkhoven R; Te Riele H; van den Brekel MW; Verheij M; Begg AC
    Clin Cancer Res; 2015 Dec; 21(24):5630-8. PubMed ID: 26265694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
    Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
    J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
    Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
    Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.
    Skinner HD; Giri U; Yang L; Woo SH; Story MD; Pickering CR; Byers LA; Williams MD; El-Naggar A; Wang J; Diao L; Shen L; Fan YH; Molkentine DP; Beadle BM; Meyn RE; Myers JN; Heymach JV
    Clin Cancer Res; 2016 Sep; 22(18):4643-50. PubMed ID: 27036135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.
    Skinner HD; Sandulache VC; Ow TJ; Meyn RE; Yordy JS; Beadle BM; Fitzgerald AL; Giri U; Ang KK; Myers JN
    Clin Cancer Res; 2012 Jan; 18(1):290-300. PubMed ID: 22090360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells.
    Guan L; Nambiar DK; Cao H; Viswanathan V; Kwok S; Hui AB; Hou Y; Hildebrand R; von Eyben R; Holmes BJ; Zhao J; Kong CS; Wamsley N; Zhang W; Major MB; Seol SW; Sunwoo JB; Hayes DN; Diehn M; Le QT
    Cancer Res; 2023 Mar; 83(6):861-874. PubMed ID: 36652552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck.
    Akervall J; Nandalur S; Zhang J; Qian CN; Goldstein N; Gyllerup P; Gardinger Y; Alm J; Lorenc K; Nilsson K; Resau J; Wilson G; Teh B
    Eur J Cancer; 2014 Feb; 50(3):570-81. PubMed ID: 24332450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer.
    Pattje WJ; Schuuring E; Mastik MF; Slagter-Menkema L; Schrijvers ML; Alessi S; van der Laan BF; Roodenburg JL; Langendijk JA; van der Wal JE
    Br J Cancer; 2010 Jun; 102(12):1778-85. PubMed ID: 20502457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-Seq analysis of peripheral blood mononuclear cells reveals unique transcriptional signatures associated with radiotherapy response of nasopharyngeal carcinoma and prognosis of head and neck cancer.
    Liu G; Zeng X; Wu B; Zhao J; Pan Y
    Cancer Biol Ther; 2020; 21(2):139-146. PubMed ID: 31698994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse.
    Seifert M; Peitzsch C; Gorodetska I; Börner C; Klink B; Dubrovska A
    PLoS Comput Biol; 2019 Nov; 15(11):e1007460. PubMed ID: 31682594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair.
    Deville SS; Delgadillo Silva LF; Vehlow A; Cordes N
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.
    Weichselbaum RR; Dahlberg W; Beckett M; Karrison T; Miller D; Clark J; Ervin TJ
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2684-8. PubMed ID: 3458227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.